Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies
15. Oktober 2024 10:31 ET
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Inbiome Receives FDA Breakthrough Device Designation for Revolutionary Molecular Culture ID Technology, Transforming Bacterial Diagnostics
26. September 2024 04:03 ET
|
inbiome
www.inbiome.com More precise diagnostics lead to quicker, more accurate patient treatment, saving lives and improving patient outcomesUS market introduction foreseen early 2026 ...
Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%
02. September 2024 05:59 ET
|
Research and Markets
Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Impetigo Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Impetigo Drugs was...
Global Antibiotic Resistance Market to Exhibit Growth at a CAGR of ~6% by 2030| DelveInsight
25. Juli 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, July 25, 2024 (GLOBE NEWSWIRE) -- Global Antibiotic Resistance Market to Exhibit Growth at a CAGR of ~6% by 2030| DelveInsight The rising challenge of antibiotic-resistant...
Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush
27. Mai 2024 03:01 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
Glycopeptide Antibiotics Global Market Report 2024: Forecast to Reach $5.02 Billion by 2028 - Long-term Forecast to 2028 and 2033
25. Januar 2024 04:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Glycopeptide Antibiotics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global glycopeptide antibiotics...
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging
22. Januar 2024 05:18 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas...
New Research Shows Link Between Air Pollution Levels and Antibiotic Resistance
09. Oktober 2023 18:00 ET
|
Camfil USA
Riverdale, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Riverdale, NJ — Antibiotic resistance poses a major threat to public health, resulting in approximately 700,000 premature deaths worldwide annually....
Global Antibiotic Resistance Markets, 2023-2027: Beyond Antibiotics - Exploring Cutting-Edge Trends in AMR Solutions
05. Oktober 2023 06:43 ET
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
10. August 2023 16:15 ET
|
OpGen, Inc.
Total revenue for the first half of 2023 was approximately $1.65 million, an increase of approximately 15% compared to approximately $1.44 million in the first half of 2022Signed FIND R&D...